Medical Blog About Treatment Abroad

Facing colon cancer feels overwhelming, but you have more treatment options than ever before. While treatment for colon cancer stage 1 provides 90% five-year survival rates, even advanced cases now benefit from breakthrough therapies that deliver chemotherapy directly to tumor sites, harness your immune system's power, and use precision...

Breast cancer immunotherapy represents a groundbreaking advancement in oncology, encompassing various innovative approaches to cancer treatment. German clinics are at the forefront of implementing these advanced therapies, from immune checkpoint inhibitors to dendritic cell vaccines – the latter made possible by Ralph Steinman... 

Transarterial Chemoembolization (TACE) is one of the most widely used and effective minimally invasive treatments for liver tumors and other cancers with localized blood supply. As technology and oncology have evolved, TACE has become even more precise and personalized in 2025, offering patients new hope - especially when surgery...

Breast cancer remains one of the most common and challenging diseases affecting women worldwide. According to the breast cancer statistics provided by the World Health Organization, more than 2.3 million women were diagnosed with breast cancer in 2022, and over 670,000 deaths were attributed to the disease globally.

Ovarian cancer is one of the most common gynecologic cancers, it ranks second in incidence among all types of cancer. It is most often diagnosed in women over 40-45 years old. Screening and increased awareness are crucial in detecting ovarian cancer early before it reaches stage 4, a terminal phase often accompanied by severe pain...

In Germany, prostate cancer is treated in large multidisciplinary university hospitals, as well as specialized centers of prostate cancer treatment and radiation therapy. With over 50 specialized centers achieving 5-year survival rates above 90% for localized disease, Germany offers advanced therapeutic options.

Colon cancer (ICD C18) is one of the five most common malignant tumors in the world, ranking third overall. While the average age of most patients is 60-75 years, the disease can also develop in individuals between 35-50 years old. Favorable treatment outcomes and colon cancer prognosis, even at stage 4 cancer, can be achieved with the usage...

Among middle-aged and elderly men worldwide, prostate cancer (PCa) stands as a significant health threat. The American Cancer Society's prognosis expects around 313,780 new prostate cancer cases in 2025, and a huge number of approximately 35,770 men are expected to die from this disease. This translates to one man being...